INTERVIEW. Dinushika Dissanayake is a lawyer and has practiced in the Supreme Court and Court of Appeal in Colombo. As both a professional and an activist, she personally works for a transitional justice in Sri Lanka and for the respect...
Programs, actions & initiatives
Denis Mukwege, laureate of the 2013 Fondation Chirac Prize for Conflict Prevention, has been awarded the very first Prize for Democracy and Human Rights by the Parliament of the Federation of Wallonia-Brussels.
Developing countries are by far the most affected by the traffic of falsified medicine. According to the World Health Organization (WHO), 30% of all medication on the market in these countries is falsified.
France is one of the countries least hit by the scourge of falsified medical products. Could its unique health system be the explanation?
Long considered efficient and safe, European health systems are being threatened by falsified medical products.
The scourge of falsified medicines is rarely featured in the media and is little understood by the general public and political authorities. Becoming aware of the problem is the first, essential step to effectively battle the scourge and to better protect Public Health.
The traffic of falsified medical products has become a global scourge with multiple causes. All possible means must be used to end this growing threat to public health.
On June 5, 2015, the Union des fabricants pour la protection internationale de la propriété intellectuelle (UNIFAB) celebrated World Anti-Counterfeiting Day. It is a perfect chance to reiterate the extent of the phenomenon and its associated risks.
Counterfeit medical products are a scourge whose exponential development is threatening the health of hundreds of thousands of people across the globe.
A growing number of organizations and associations of all sorts are involved in the fight against falsified medical products. Here are a few of the most important actors in the battle.